Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Nasal Drops Market by Type (Corticosteroids, Bronchodilators, Combinations, Decongestant Sprays, Others), By Application (Asthma, COPD, Allergic Rhinitis, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Nasal Drops Market by Type (Corticosteroids, Bronchodilators, Combinations, Decongestant Sprays, Others), By Application (Asthma, COPD, Allergic Rhinitis, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 133769 3300 Pharma & Healthcare 377 248 Pages 4.6 (41)
                                          

The global nasal drops market is expected to grow at a CAGR of 4.5% during the forecast period, to reach USD 1.2 billion by 2030. The growth of this market is driven by factors such as increasing prevalence of allergic rhinitis and asthma, growing awareness about the benefits of nasal drops for treating these conditions, and increasing number of patients with chronic obstructive pulmonary disease (COPD). The global nasal drops market is segmented on the basis of type into corticosteroids, bronchodilators, combinations and decongestant sprays; on the basis of application into asthma, COPD and allergic rhinitis; and on the basis of region into North America, Latin America, Europe Asia Pacific (APAC) and Middle East & Africa (MEA). Nasal Drops market growth factors are the driving forces that will help the Nasal Drops market to grow. The Nasal Drops market is expected to grow at a CAGR of XX% during the forecast period.

Industry Growth Insights published a new data on “Nasal Drops Market”. The research report is titled “Nasal Drops Market research by Types (Corticosteroids, Bronchodilators, Combinations, Decongestant Sprays, Others), By Applications (Asthma, COPD, Allergic Rhinitis, Other), By Players/Companies Teva, Sandoz (Novartis AG), Mylan, Allergan PLC, Cipla, Akorn, Apotex, Sun Pharma (Ranbaxy), Nephron Pharma, Beximco Pharma, Hikma (Roxane), XIANJU PHARMA”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Nasal Drops Market Research Report

By Type

Corticosteroids, Bronchodilators, Combinations, Decongestant Sprays, Others

By Application

Asthma, COPD, Allergic Rhinitis, Other

By Companies

Teva, Sandoz (Novartis AG), Mylan, Allergan PLC, Cipla, Akorn, Apotex, Sun Pharma (Ranbaxy), Nephron Pharma, Beximco Pharma, Hikma (Roxane), XIANJU PHARMA

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

248

Number of Tables & Figures

174

Customization Available

Yes, the report can be customized as per your need.


Global Nasal Drops Industry Outlook


Global Nasal Drops Market Report Segments:

The global Nasal Drops market is segmented on the basis of:

Types

Corticosteroids, Bronchodilators, Combinations, Decongestant Sprays, Others

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Asthma, COPD, Allergic Rhinitis, Other

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Teva
  2. Sandoz (Novartis AG)
  3. Mylan
  4. Allergan PLC
  5. Cipla
  6. Akorn
  7. Apotex
  8. Sun Pharma (Ranbaxy)
  9. Nephron Pharma
  10. Beximco Pharma
  11. Hikma (Roxane)
  12. XIANJU PHARMA

Global Nasal Drops Market Overview


Highlights of The Nasal Drops Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Corticosteroids
    2. Bronchodilators
    3. Combinations
    4. Decongestant Sprays
    5. Others
  1. By Application:

    1. Asthma
    2. COPD
    3. Allergic Rhinitis
    4. Other
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Nasal Drops Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Nasal Drops Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Nasal drops are a type of over-the-counter medication that is used to treat congestion and nasal dryness. Nasal drops can be purchased at most pharmacies or grocery stores.

Some of the key players operating in the nasal drops market are Teva, Sandoz (Novartis AG), Mylan, Allergan PLC, Cipla, Akorn, Apotex, Sun Pharma (Ranbaxy), Nephron Pharma, Beximco Pharma, Hikma (Roxane), XIANJU PHARMA.

The nasal drops market is expected to grow at a compound annual growth rate of 4.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Nasal Drops Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Nasal Drops Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Nasal Drops Market - Supply Chain
   4.5. Global Nasal Drops Market Forecast
      4.5.1. Nasal Drops Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Nasal Drops Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Nasal Drops Market Absolute $ Opportunity

5. Global Nasal Drops Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Nasal Drops Market Size and Volume Forecast by Type
      5.3.1. Corticosteroids
      5.3.2. Bronchodilators
      5.3.3. Combinations
      5.3.4. Decongestant Sprays
      5.3.5. Others
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Nasal Drops Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Nasal Drops Market Size and Volume Forecast by Application
      6.3.1. Asthma
      6.3.2. COPD
      6.3.3. Allergic Rhinitis
      6.3.4. Other
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Nasal Drops Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Nasal Drops Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Nasal Drops Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Nasal Drops Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Nasal Drops Demand Share Forecast, 2019-2029

9. North America Nasal Drops Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Nasal Drops Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Nasal Drops Market Size and Volume Forecast by Application
      9.4.1. Asthma
      9.4.2. COPD
      9.4.3. Allergic Rhinitis
      9.4.4. Other
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Nasal Drops Market Size and Volume Forecast by Type
      9.7.1. Corticosteroids
      9.7.2. Bronchodilators
      9.7.3. Combinations
      9.7.4. Decongestant Sprays
      9.7.5. Others
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Nasal Drops Demand Share Forecast, 2019-2029

10. Latin America Nasal Drops Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Nasal Drops Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Nasal Drops Market Size and Volume Forecast by Application
      10.4.1. Asthma
      10.4.2. COPD
      10.4.3. Allergic Rhinitis
      10.4.4. Other
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Nasal Drops Market Size and Volume Forecast by Type
      10.7.1. Corticosteroids
      10.7.2. Bronchodilators
      10.7.3. Combinations
      10.7.4. Decongestant Sprays
      10.7.5. Others
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Nasal Drops Demand Share Forecast, 2019-2029

11. Europe Nasal Drops Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Nasal Drops Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Nasal Drops Market Size and Volume Forecast by Application
      11.4.1. Asthma
      11.4.2. COPD
      11.4.3. Allergic Rhinitis
      11.4.4. Other
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Nasal Drops Market Size and Volume Forecast by Type
      11.7.1. Corticosteroids
      11.7.2. Bronchodilators
      11.7.3. Combinations
      11.7.4. Decongestant Sprays
      11.7.5. Others
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Nasal Drops Demand Share, 2019-2029

12. Asia Pacific Nasal Drops Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Nasal Drops Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Nasal Drops Market Size and Volume Forecast by Application
      12.4.1. Asthma
      12.4.2. COPD
      12.4.3. Allergic Rhinitis
      12.4.4. Other
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Nasal Drops Market Size and Volume Forecast by Type
      12.7.1. Corticosteroids
      12.7.2. Bronchodilators
      12.7.3. Combinations
      12.7.4. Decongestant Sprays
      12.7.5. Others
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Nasal Drops Demand Share, 2019-2029

13. Middle East & Africa Nasal Drops Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Nasal Drops Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Nasal Drops Market Size and Volume Forecast by Application
      13.4.1. Asthma
      13.4.2. COPD
      13.4.3. Allergic Rhinitis
      13.4.4. Other
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Nasal Drops Market Size and Volume Forecast by Type
      13.7.1. Corticosteroids
      13.7.2. Bronchodilators
      13.7.3. Combinations
      13.7.4. Decongestant Sprays
      13.7.5. Others
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Nasal Drops Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Nasal Drops Market: Market Share Analysis
   14.2. Nasal Drops Distributors and Customers
   14.3. Nasal Drops Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Teva
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Sandoz (Novartis AG)
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Mylan
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Allergan PLC
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Cipla
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Akorn
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Apotex
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Sun Pharma (Ranbaxy)
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Nephron Pharma
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Beximco Pharma
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. Hikma (Roxane)
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. XIANJU PHARMA
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us